[Digital Leading Company] Miracell
Local medical device market size: approximately 9 trillion won… Introducing proprietary new technology, “Smart M-Cell”
Over 70 teams visited… Popular in hair loss and men’s health
Following European academia, Miracell enters the Middle East market in earnest… Participating in Germany’s “Medica 2025” from the 17th to the 20th
Stem cell specialist Miracell Co., Ltd. announced its participation in the “2025 Global Health Exhibition,” held at the Riyadh International Convention and Exhibition Center in Saudi Arabia from the 27th to the 30th of last month.
Hosted by the Saudi Arabian Ministry of Health, the exhibition was themed “Invest in Health.”
Global interest in regenerative medicine, including extending healthy lifespan, preventing chronic diseases, and delaying aging, garnered attention for the latest stem cell treatment technologies.
This year’s exhibition attracted over 100,000 medical professionals and 2,000 companies from around the world, engaging in active exchanges and offering various workshops and sessions with over 500 speakers. In particular, key agenda items included digital health, AI-based diagnostics, preventive medicine, and the establishment of global partnerships, all aligned with the Saudi government’s Vision 2030 program for transforming the medical and healthcare industry.
Miracell is accelerating its penetration of the Middle East market with the launch of its proprietary stem cell extraction system, “Smart Mcell.”
Smart Mcell is currently being used in hospitals in Dubai, the United Arab Emirates (UAE), Kuwait, and elsewhere.
Miracell is actively pursuing global marketing, participating in the international skin care exhibition “Dubai Derma” and touring key countries such as Qatar, Saudi Arabia, and Jordan.
Park Tae-min, Director of Miracell’s Global Business Division, stated, “The Middle East, including Saudi Arabia, is rapidly expanding and localizing its healthcare industry. In particular, investment in premium healthcare in the areas of anti-aging, beauty, regeneration, and wellness is rapidly growing.” He added, “In a market with high demand for stem cell treatments, Miracell, known as the ‘King of Stem Cells’ and a leader in K-medical, participated in this exhibition to widely promote its technological prowess and discover new partners.”
He continued, “During the event, approximately 70 teams, primarily from the Middle East, visited the Miracell booth, and there was strong interest in male energy and hair loss treatment.”
He added, “Smart M-Cell concentrated CD34+ hematopoietic stem cells up to 282 times more efficiently than existing systems, with a cell viability rate of approximately 99%, generating explosive interest among Middle Eastern medical professionals.”
The Saudi medical device market is expected to be worth approximately $6.42 billion (approximately KRW 9.3 trillion) in 2025 and grow to approximately $8.23 billion (approximately KRW 11.9 trillion) by 2030.
With over 90% of its medical devices imported, the Saudi market presents significant opportunities, but also faces stringent regulations.
Director Park explained, “Saudi Arabia places strict emphasis on safety and quality, making the medical device registration and approval process extremely rigorous. However, Miracell’s Smart M-Cell has been highly evaluated for its performance and safety among medical professionals, and is on the verge of entering the Saudi market.”
Smart M-Cell is a biomedical device that isolates and concentrates stem cells and regenerative cells from blood or bone marrow for regenerative medicine. It has been designated as a New Excellent Technology (NET) by the Ministry of Health and Welfare and registered with the U.S. Food and Drug Administration (FDA). It is currently being used in various clinical areas, including knee osteoarthritis and anti-aging treatments. Miracell’s SmartMcell is already attracting attention in the European market. At the European Symposium on Regenerative Medicine held in Serbia last September, Dr. Vladimir Jovanović (a regenerative medicine expert under the Serbian Ministry of Health) and Dr. Yelena presented the results of a three-year clinical trial using SmartMcell, drawing attention and being broadcast on national television.
Furthermore, at the World Pain Congress held in Spain last October, Greek hematologist Dr. Ilias Theodoropoulos announced, “We have demonstrated the efficacy of SmartMcell stem cell therapy in treating rheumatic pain and anti-aging through over 400 cases of SmartMcell stem cell therapy over the past year,” drawing attention from the global academic community.
Miracell plans to further strengthen its position in the Middle East market through this Saudi exhibition and to showcase SmartMcell’s technological prowess and clinical competitiveness to the world by participating in Medica 2025, the world’s largest medical device exhibition, held in Düsseldorf, Germany, from the 17th to the 20th.
Meanwhile, Miracell has developed and launched the world’s first light energy cell activation bio-equipment, the “Chroma M-Cell” ringer bag cover.
The device can be tailored to a patient’s symptoms with four color wavelengths, helping to improve cell condition and enhance efficacy and stability during stem cell treatments.
Source: Donga Ilbo (https://www.donga.com/news/Health/article/all/20251110/132725721/2)